Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm copanlisib in relapsed or refractory diffuse large B-cell lymphoma
2014-004848-36Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of copanlisib in diffuse large B-cell lymphoma (DLBCL), sponsored by Bayer. Primary endpoint: Objective response rate. Started Mar 2015; status: completed.
02
Drugs
copanlisib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2014-004848-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004848-36.